Global Safety Lancets for Diabetes Market Growth 2022-2028
Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor's offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.
The global market for Safety Lancets for Diabetes is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Safety Lancets for Diabetes market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Safety Lancets for Diabetes market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Safety Lancets for Diabetes market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Safety Lancets for Diabetes market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Safety Lancets for Diabetes players cover Roche, BD, Ascensia, Lifescan and B. Braun, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Safety Lancets for Diabetes market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Safety Lancets for Diabetes market, with both quantitative and qualitative data, to help readers understand how the Safety Lancets for Diabetes market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.
Market Segmentation:
The study segments the Safety Lancets for Diabetes market and forecasts the market size by Type (Safety Lancets with Needle and Safety Lancets with Blade,), by Application (Hospital & Clinics, Home and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Safety Lancets with Needle
Safety Lancets with Blade
Segmentation by application
Hospital & Clinics
Home
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
Chapter Introduction
Chapter 1: Scope of Safety Lancets for Diabetes, Research Methodology, etc.
Chapter 2: Executive Summary, global Safety Lancets for Diabetes market size (sales and revenue) and CAGR, Safety Lancets for Diabetes market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Safety Lancets for Diabetes sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Safety Lancets for Diabetes sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Safety Lancets for Diabetes market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Roche, BD, Ascensia, Lifescan, B. Braun, Terumo, Nipro, Cardinal Health and ARKRAY, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Safety Lancets for Diabetes Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Safety Lancets for Diabetes by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Safety Lancets for Diabetes by Country/Region, 2017, 2022 & 2028
2.2 Safety Lancets for Diabetes Segment by Type
2.2.1 Safety Lancets with Needle
2.2.2 Safety Lancets with Blade
2.3 Safety Lancets for Diabetes Sales by Type
2.3.1 Global Safety Lancets for Diabetes Sales Market Share by Type (2017-2022)
2.3.2 Global Safety Lancets for Diabetes Revenue and Market Share by Type (2017-2022)
2.3.3 Global Safety Lancets for Diabetes Sale Price by Type (2017-2022)
2.4 Safety Lancets for Diabetes Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Home
2.4.3 Other
2.5 Safety Lancets for Diabetes Sales by Application
2.5.1 Global Safety Lancets for Diabetes Sale Market Share by Application (2017-2022)
2.5.2 Global Safety Lancets for Diabetes Revenue and Market Share by Application (2017-2022)
2.5.3 Global Safety Lancets for Diabetes Sale Price by Application (2017-2022)
3 Global Safety Lancets for Diabetes by Company
3.1 Global Safety Lancets for Diabetes Breakdown Data by Company
3.1.1 Global Safety Lancets for Diabetes Annual Sales by Company (2020-2022)
3.1.2 Global Safety Lancets for Diabetes Sales Market Share by Company (2020-2022)
3.2 Global Safety Lancets for Diabetes Annual Revenue by Company (2020-2022)
3.2.1 Global Safety Lancets for Diabetes Revenue by Company (2020-2022)
3.2.2 Global Safety Lancets for Diabetes Revenue Market Share by Company (2020-2022)
3.3 Global Safety Lancets for Diabetes Sale Price by Company
3.4 Key Manufacturers Safety Lancets for Diabetes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Safety Lancets for Diabetes Product Location Distribution
3.4.2 Players Safety Lancets for Diabetes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Safety Lancets for Diabetes by Geographic Region
4.1 World Historic Safety Lancets for Diabetes Market Size by Geographic Region (2017-2022)
4.1.1 Global Safety Lancets for Diabetes Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Safety Lancets for Diabetes Annual Revenue by Geographic Region
4.2 World Historic Safety Lancets for Diabetes Market Size by Country/Region (2017-2022)
4.2.1 Global Safety Lancets for Diabetes Annual Sales by Country/Region (2017-2022)
4.2.2 Global Safety Lancets for Diabetes Annual Revenue by Country/Region
4.3 Americas Safety Lancets for Diabetes Sales Growth
4.4 APAC Safety Lancets for Diabetes Sales Growth
4.5 Europe Safety Lancets for Diabetes Sales Growth
4.6 Middle East & Africa Safety Lancets for Diabetes Sales Growth
5 Americas
5.1 Americas Safety Lancets for Diabetes Sales by Country
5.1.1 Americas Safety Lancets for Diabetes Sales by Country (2017-2022)
5.1.2 Americas Safety Lancets for Diabetes Revenue by Country (2017-2022)
5.2 Americas Safety Lancets for Diabetes Sales by Type
5.3 Americas Safety Lancets for Diabetes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Safety Lancets for Diabetes Sales by Region
6.1.1 APAC Safety Lancets for Diabetes Sales by Region (2017-2022)
6.1.2 APAC Safety Lancets for Diabetes Revenue by Region (2017-2022)
6.2 APAC Safety Lancets for Diabetes Sales by Type
6.3 APAC Safety Lancets for Diabetes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Safety Lancets for Diabetes by Country
7.1.1 Europe Safety Lancets for Diabetes Sales by Country (2017-2022)
7.1.2 Europe Safety Lancets for Diabetes Revenue by Country (2017-2022)
7.2 Europe Safety Lancets for Diabetes Sales by Type
7.3 Europe Safety Lancets for Diabetes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Safety Lancets for Diabetes by Country
8.1.1 Middle East & Africa Safety Lancets for Diabetes Sales by Country (2017-2022)
8.1.2 Middle East & Africa Safety Lancets for Diabetes Revenue by Country (2017-2022)
8.2 Middle East & Africa Safety Lancets for Diabetes Sales by Type
8.3 Middle East & Africa Safety Lancets for Diabetes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Safety Lancets for Diabetes
10.3 Manufacturing Process Analysis of Safety Lancets for Diabetes
10.4 Industry Chain Structure of Safety Lancets for Diabetes
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Safety Lancets for Diabetes Distributors
11.3 Safety Lancets for Diabetes Customer
12 World Forecast Review for Safety Lancets for Diabetes by Geographic Region
12.1 Global Safety Lancets for Diabetes Market Size Forecast by Region
12.1.1 Global Safety Lancets for Diabetes Forecast by Region (2023-2028)
12.1.2 Global Safety Lancets for Diabetes Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Safety Lancets for Diabetes Forecast by Type
12.7 Global Safety Lancets for Diabetes Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Safety Lancets for Diabetes Product Offered
13.1.3 Roche Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Safety Lancets for Diabetes Product Offered
13.2.3 BD Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Ascensia
13.3.1 Ascensia Company Information
13.3.2 Ascensia Safety Lancets for Diabetes Product Offered
13.3.3 Ascensia Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Ascensia Main Business Overview
13.3.5 Ascensia Latest Developments
13.4 Lifescan
13.4.1 Lifescan Company Information
13.4.2 Lifescan Safety Lancets for Diabetes Product Offered
13.4.3 Lifescan Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lifescan Main Business Overview
13.4.5 Lifescan Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Safety Lancets for Diabetes Product Offered
13.5.3 B. Braun Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Safety Lancets for Diabetes Product Offered
13.6.3 Terumo Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 Nipro
13.7.1 Nipro Company Information
13.7.2 Nipro Safety Lancets for Diabetes Product Offered
13.7.3 Nipro Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Nipro Main Business Overview
13.7.5 Nipro Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Safety Lancets for Diabetes Product Offered
13.8.3 Cardinal Health Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
13.9 ARKRAY
13.9.1 ARKRAY Company Information
13.9.2 ARKRAY Safety Lancets for Diabetes Product Offered
13.9.3 ARKRAY Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 ARKRAY Main Business Overview
13.9.5 ARKRAY Latest Developments
13.10 ICU Medical
13.10.1 ICU Medical Company Information
13.10.2 ICU Medical Safety Lancets for Diabetes Product Offered
13.10.3 ICU Medical Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 ICU Medical Main Business Overview
13.10.5 ICU Medical Latest Developments
13.11 Owen Mumford
13.11.1 Owen Mumford Company Information
13.11.2 Owen Mumford Safety Lancets for Diabetes Product Offered
13.11.3 Owen Mumford Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Owen Mumford Main Business Overview
13.11.5 Owen Mumford Latest Developments
13.12 HemoCue
13.12.1 HemoCue Company Information
13.12.2 HemoCue Safety Lancets for Diabetes Product Offered
13.12.3 HemoCue Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 HemoCue Main Business Overview
13.12.5 HemoCue Latest Developments
13.13 Greiner Bio One
13.13.1 Greiner Bio One Company Information
13.13.2 Greiner Bio One Safety Lancets for Diabetes Product Offered
13.13.3 Greiner Bio One Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Greiner Bio One Main Business Overview
13.13.5 Greiner Bio One Latest Developments
13.14 HTL-STREFA
13.14.1 HTL-STREFA Company Information
13.14.2 HTL-STREFA Safety Lancets for Diabetes Product Offered
13.14.3 HTL-STREFA Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 HTL-STREFA Main Business Overview
13.14.5 HTL-STREFA Latest Developments
13.15 Sarstedt
13.15.1 Sarstedt Company Information
13.15.2 Sarstedt Safety Lancets for Diabetes Product Offered
13.15.3 Sarstedt Safety Lancets for Diabetes Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Sarstedt Main Business Overview
13.15.5 Sarstedt Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Safety Lancets for Diabetes Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Safety Lancets for Diabetes Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Safety Lancets with Needle
Table 4. Major Players of Safety Lancets with Blade
Table 5. Global Safety Lancets for Diabetes Sales by Type (2017-2022) & (Units)
Table 6. Global Safety Lancets for Diabetes Sales Market Share by Type (2017-2022)
Table 7. Global Safety Lancets for Diabetes Revenue by Type (2017-2022) & ($ million)
Table 8. Global Safety Lancets for Diabetes Revenue Market Share by Type (2017-2022)
Table 9. Global Safety Lancets for Diabetes Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Safety Lancets for Diabetes Sales by Application (2017-2022) & (Units)
Table 11. Global Safety Lancets for Diabetes Sales Market Share by Application (2017-2022)
Table 12. Global Safety Lancets for Diabetes Revenue by Application (2017-2022)
Table 13. Global Safety Lancets for Diabetes Revenue Market Share by Application (2017-2022)
Table 14. Global Safety Lancets for Diabetes Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Safety Lancets for Diabetes Sales by Company (2020-2022) & (Units)
Table 16. Global Safety Lancets for Diabetes Sales Market Share by Company (2020-2022)
Table 17. Global Safety Lancets for Diabetes Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Safety Lancets for Diabetes Revenue Market Share by Company (2020-2022)
Table 19. Global Safety Lancets for Diabetes Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Safety Lancets for Diabetes Producing Area Distribution and Sales Area
Table 21. Players Safety Lancets for Diabetes Products Offered
Table 22. Safety Lancets for Diabetes Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Safety Lancets for Diabetes Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Safety Lancets for Diabetes Sales Market Share Geographic Region (2017-2022)
Table 27. Global Safety Lancets for Diabetes Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Safety Lancets for Diabetes Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Safety Lancets for Diabetes Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Safety Lancets for Diabetes Sales Market Share by Country/Region (2017-2022)
Table 31. Global Safety Lancets for Diabetes Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Safety Lancets for Diabetes Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Safety Lancets for Diabetes Sales by Country (2017-2022) & (Units)
Table 34. Americas Safety Lancets for Diabetes Sales Market Share by Country (2017-2022)
Table 35. Americas Safety Lancets for Diabetes Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Safety Lancets for Diabetes Revenue Market Share by Country (2017-2022)
Table 37. Americas Safety Lancets for Diabetes Sales by Type (2017-2022) & (Units)
Table 38. Americas Safety Lancets for Diabetes Sales Market Share by Type (2017-2022)
Table 39. Americas Safety Lancets for Diabetes Sales by Application (2017-2022) & (Units)
Table 40. Americas Safety Lancets for Diabetes Sales Market Share by Application (2017-2022)
Table 41. APAC Safety Lancets for Diabetes Sales by Region (2017-2022) & (Units)
Table 42. APAC Safety Lancets for Diabetes Sales Market Share by Region (2017-2022)
Table 43. APAC Safety Lancets for Diabetes Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Safety Lancets for Diabetes Revenue Market Share by Region (2017-2022)
Table 45. APAC Safety Lancets for Diabetes Sales by Type (2017-2022) & (Units)
Table 46. APAC Safety Lancets for Diabetes Sales Market Share by Type (2017-2022)
Table 47. APAC Safety Lancets for Diabetes Sales by Application (2017-2022) & (Units)
Table 48. APAC Safety Lancets for Diabetes Sales Market Share by Application (2017-2022)
Table 49. Europe Safety Lancets for Diabetes Sales by Country (2017-2022) & (Units)
Table 50. Europe Safety Lancets for Diabetes Sales Market Share by Country (2017-2022)
Table 51. Europe Safety Lancets for Diabetes Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Safety Lancets for Diabetes Revenue Market Share by Country (2017-2022)
Table 53. Europe Safety Lancets for Diabetes Sales by Type (2017-2022) & (Units)
Table 54. Europe Safety Lancets for Diabetes Sales Market Share by Type (2017-2022)
Table 55. Europe Safety Lancets for Diabetes Sales by Application (2017-2022) & (Units)
Table 56. Europe Safety Lancets for Diabetes Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Safety Lancets for Diabetes Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Safety Lancets for Diabetes Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Safety Lancets for Diabetes Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Safety Lancets for Diabetes Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Safety Lancets for Diabetes Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Safety Lancets for Diabetes Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Safety Lancets for Diabetes Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Safety Lancets for Diabetes Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Safety Lancets for Diabetes
Table 66. Key Market Challenges & Risks of Safety Lancets for Diabetes
Table 67. Key Industry Trends of Safety Lancets for Diabetes
Table 68. Safety Lancets for Diabetes Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Safety Lancets for Diabetes Distributors List
Table 71. Safety Lancets for Diabetes Customer List
Table 72. Global Safety Lancets for Diabetes Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Safety Lancets for Diabetes Sales Market Forecast by Region
Table 74. Global Safety Lancets for Diabetes Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Safety Lancets for Diabetes Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Safety Lancets for Diabetes Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Safety Lancets for Diabetes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Safety Lancets for Diabetes Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Safety Lancets for Diabetes Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Safety Lancets for Diabetes Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Safety Lancets for Diabetes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Safety Lancets for Diabetes Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Safety Lancets for Diabetes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Safety Lancets for Diabetes Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Safety Lancets for Diabetes Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Safety Lancets for Diabetes Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Safety Lancets for Diabetes Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Safety Lancets for Diabetes Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Safety Lancets for Diabetes Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Safety Lancets for Diabetes Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Safety Lancets for Diabetes Revenue Market Share Forecast by Application (2023-2028)
Table 92. Roche Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Safety Lancets for Diabetes Product Offered
Table 94. Roche Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
Table 97. BD Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 98. BD Safety Lancets for Diabetes Product Offered
Table 99. BD Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. BD Main Business
Table 101. BD Latest Developments
Table 102. Ascensia Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 103. Ascensia Safety Lancets for Diabetes Product Offered
Table 104. Ascensia Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Ascensia Main Business
Table 106. Ascensia Latest Developments
Table 107. Lifescan Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 108. Lifescan Safety Lancets for Diabetes Product Offered
Table 109. Lifescan Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Lifescan Main Business
Table 111. Lifescan Latest Developments
Table 112. B. Braun Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 113. B. Braun Safety Lancets for Diabetes Product Offered
Table 114. B. Braun Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. B. Braun Main Business
Table 116. B. Braun Latest Developments
Table 117. Terumo Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 118. Terumo Safety Lancets for Diabetes Product Offered
Table 119. Terumo Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Terumo Main Business
Table 121. Terumo Latest Developments
Table 122. Nipro Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 123. Nipro Safety Lancets for Diabetes Product Offered
Table 124. Nipro Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Nipro Main Business
Table 126. Nipro Latest Developments
Table 127. Cardinal Health Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 128. Cardinal Health Safety Lancets for Diabetes Product Offered
Table 129. Cardinal Health Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Cardinal Health Main Business
Table 131. Cardinal Health Latest Developments
Table 132. ARKRAY Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 133. ARKRAY Safety Lancets for Diabetes Product Offered
Table 134. ARKRAY Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. ARKRAY Main Business
Table 136. ARKRAY Latest Developments
Table 137. ICU Medical Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 138. ICU Medical Safety Lancets for Diabetes Product Offered
Table 139. ICU Medical Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. ICU Medical Main Business
Table 141. ICU Medical Latest Developments
Table 142. Owen Mumford Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 143. Owen Mumford Safety Lancets for Diabetes Product Offered
Table 144. Owen Mumford Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Owen Mumford Main Business
Table 146. Owen Mumford Latest Developments
Table 147. HemoCue Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 148. HemoCue Safety Lancets for Diabetes Product Offered
Table 149. HemoCue Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. HemoCue Main Business
Table 151. HemoCue Latest Developments
Table 152. Greiner Bio One Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 153. Greiner Bio One Safety Lancets for Diabetes Product Offered
Table 154. Greiner Bio One Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Greiner Bio One Main Business
Table 156. Greiner Bio One Latest Developments
Table 157. HTL-STREFA Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 158. HTL-STREFA Safety Lancets for Diabetes Product Offered
Table 159. HTL-STREFA Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. HTL-STREFA Main Business
Table 161. HTL-STREFA Latest Developments
Table 162. Sarstedt Basic Information, Safety Lancets for Diabetes Manufacturing Base, Sales Area and Its Competitors
Table 163. Sarstedt Safety Lancets for Diabetes Product Offered
Table 164. Sarstedt Safety Lancets for Diabetes Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Sarstedt Main Business
Table 166. Sarstedt Latest Developments
List of Figures
Figure 1. Picture of Safety Lancets for Diabetes
Figure 2. Safety Lancets for Diabetes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Safety Lancets for Diabetes Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Safety Lancets for Diabetes Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Safety Lancets for Diabetes Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Safety Lancets with Needle
Figure 10. Product Picture of Safety Lancets with Blade
Figure 11. Global Safety Lancets for Diabetes Sales Market Share by Type in 2021
Figure 12. Global Safety Lancets for Diabetes Revenue Market Share by Type (2017-2022)
Figure 13. Safety Lancets for Diabetes Consumed in Hospital & Clinics
Figure 14. Global Safety Lancets for Diabetes Market: Hospital & Clinics (2017-2022) & (Units)
Figure 15. Safety Lancets for Diabetes Consumed in Home
Figure 16. Global Safety Lancets for Diabetes Market: Home (2017-2022) & (Units)
Figure 17. Safety Lancets for Diabetes Consumed in Other
Figure 18. Global Safety Lancets for Diabetes Market: Other (2017-2022) & (Units)
Figure 19. Global Safety Lancets for Diabetes Sales Market Share by Application (2017-2022)
Figure 20. Global Safety Lancets for Diabetes Revenue Market Share by Application in 2021
Figure 21. Safety Lancets for Diabetes Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Safety Lancets for Diabetes Revenue Market Share by Company in 2021
Figure 23. Global Safety Lancets for Diabetes Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Safety Lancets for Diabetes Revenue Market Share by Geographic Region in 2021
Figure 25. Global Safety Lancets for Diabetes Sales Market Share by Region (2017-2022)
Figure 26. Global Safety Lancets for Diabetes Revenue Market Share by Country/Region in 2021
Figure 27. Americas Safety Lancets for Diabetes Sales 2017-2022 (Units)
Figure 28. Americas Safety Lancets for Diabetes Revenue 2017-2022 ($ Millions)
Figure 29. APAC Safety Lancets for Diabetes Sales 2017-2022 (Units)
Figure 30. APAC Safety Lancets for Diabetes Revenue 2017-2022 ($ Millions)
Figure 31. Europe Safety Lancets for Diabetes Sales 2017-2022 (Units)
Figure 32. Europe Safety Lancets for Diabetes Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Safety Lancets for Diabetes Sales 2017-2022 (Units)
Figure 34. Middle East & Africa Safety Lancets for Diabetes Revenue 2017-2022 ($ Millions)
Figure 35. Americas Safety Lancets for Diabetes Sales Market Share by Country in 2021
Figure 36. Americas Safety Lancets for Diabetes Revenue Market Share by Country in 2021
Figure 37. United States Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Safety Lancets for Diabetes Sales Market Share by Region in 2021
Figure 42. APAC Safety Lancets for Diabetes Revenue Market Share by Regions in 2021
Figure 43. China Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Safety Lancets for Diabetes Sales Market Share by Country in 2021
Figure 50. Europe Safety Lancets for Diabetes Revenue Market Share by Country in 2021
Figure 51. Germany Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Safety Lancets for Diabetes Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Safety Lancets for Diabetes Revenue Market Share by Country in 2021
Figure 58. Egypt Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Safety Lancets for Diabetes Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Safety Lancets for Diabetes in 2021
Figure 64. Manufacturing Process Analysis of Safety Lancets for Diabetes
Figure 65. Industry Chain Structure of Safety Lancets for Diabetes
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets